Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been confirmed through a biopsy or tissue test to have hormone receptor-positive (HR+) invasive breast cancer, meaning the cancer responds to hormones like oestrogen and/or progesterone
- People diagnosed with early-stage breast cancer (stage I to III) with no signs that the cancer has spread to other parts of the body or come back locally
- People who have a medical reason to be taking hormone-blocking treatment (such as tamoxifen or aromatase inhibitors), with or without other targeted medicines
- People who are already actively taking hormone-blocking treatment for their breast cancer at the time of joining the trial
- People who are experiencing side effects from their current hormone-blocking treatment
- People aged 18 or older
- People whose general physical ability to carry out daily activities falls within a certain functional range (confirm with trial site)
- People who own and use a smartphone
- People who are able and willing to follow the study visits and procedures as required
- People who are covered by a social security or health insurance system
- People who can easily read and understand French
- People who have had breast reconstruction may still be eligible to participate
- Men with breast cancer may be eligible to join
Who may not be able to join:
- People with serious cognitive (thinking or memory) difficulties or severe mental health conditions that, in the medical team's opinion, would make it difficult to follow the study requirements
- People who are under legal guardianship, have had their freedom restricted by a court or administrative decision, or are unable to give their own consent
- People who are already taking part in another behavioural intervention trial at the time of enrolling in this study
- People whose side effects from hormone-blocking treatment are caused by a separate, treatable physical condition — such as anaemia, an imbalance of minerals in the body, an infection, kidney problems, or a hormonal condition like an underactive thyroid — according to the doctor's judgement
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ines VAZ-LUIS, MD, Gustave Roussy, Cancer Campus, Grand Paris
Phone: +33142114211
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To determine the efficacy of a personalized approach, consisting of a multi-component, interventional mobile application in addition to standard of care, compared with standard care alone in improving quality of life (QOL) after 12 weeks.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.